Symetryx Corp 13D and 13G filings for NeuBase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-20 5:28 pm Sale | 2023-09-14 | 13D | NeuBase Therapeutics, Inc. NBSE | Symetryx Corp | 109,508 3.500% | -363,418 (-76.84%) | Filing |
| 2023-09-14 06:03 am Purchase | 2023-09-08 | 13D | NeuBase Therapeutics, Inc. NBSE | Symetryx Corp | 472,926 9.100% | 44,482 (+10.38%) | Filing |
| 2023-08-31 11:50 am Purchase | 2023-08-22 | 13D | NeuBase Therapeutics, Inc. NBSE | Symetryx Corp | 428,444 13.800% | 428,444 (New Position) | Filing |